Sfoglia per Rivista
AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN MULTIPLE MYELOMA: THE GITMO EXPERIENCE
2003-01-01 Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavaro P; Rotta M; Aitoro G; Corradini P; Todisco E; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Messina M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
2016-01-01 Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.*
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS
2015-01-01 Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
2015-01-01 Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Pasquale, R; Sica, S; Laurenti, L
Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin.
1988-01-01 VISANI G ;RIZZOLI V ;DINOTA A ;AGLIETTA M ;BERNABEI PA ;GERACI L ;LEONI P ;MANGONI L ;MELONI G ;MOTTA MR
Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis
2002-01-01 Fabris, Fabrizio; Fagioli, Franca; Basso, Giuseppe; Girolami, Antonio
B lymphocytes receptors: a new biological approach for immunofluorescence studies.
1977-01-01 CONTE PF ;BOCCADORO M ;PILERI A
A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines
2019-01-01 D'Agaro T.; Zucchetto A.; Vit F.; Bittolo T.; Tissino E.; Rossi F.M.; Degan M.; Zaja F.; Bulian P.; Bo M.D.; Ferrero S.; Ladetto M.; Zamo A.; Gattei V.; Bomben R.
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial
2018-01-01 Bomben, Riccardo; Ferrero, Simone; D'Agaro, Tiziana; Dal Bo, Michele; Re, Alessandro; Evangelista, Andrea; Carella, Angelo Michele; Zamò, Alberto; Vitolo, Umberto; Omedè, Paola; Rusconi, Chiara; Arcaini, Luca; Rigacci, Luigi; Luminari, Stefano; Piccin, Andrea; Liu, Delong; Wiestner, Adrien; Gaidano, Gianluca; Cortelazzo, Sergio; Ladetto, Marco; Gattei, Valter
Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress
2011-01-01 L. Oliva; G. Palladini; F. Cerruti; N. Pengo; P. Cascio; R. Sitia; G. Merlini; S. Cenci
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation.
2014-01-01 Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
2019-01-01 Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
2006-01-01 Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy.
2014-01-01 Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A
Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse
2005-01-01 MATTEI D; MORDINI N; VIGNA TAGLIANTI R; BRUNO B; RAPEZZI D; GALLAMINI A
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation
2006-01-01 BRUNO B; PATRIARCA F; SORASIO R; MATTEI D; MONTEFUSCO V; PECCATORI J; BONIFAZI F; PETRUCCI MT; MILONE G; GUIDI S; GIACCONE L; ROTTA M; FANIN R; BOCCADORO M; CORRADINI P
BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT)VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) INELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE,RANDOMIZED, PHASE III STUDY
2009-01-01 A. Palumbo; S. Bringhen; D. Rossi; R. Ria; S. Berretta; M. Offidani; F. Patriarca; C. Nozzoli; A. Levi; T. Guglielmelli; G. Benevolo; V. Callea; A.M. Liberati; C. Crippa; N. Di Renzo; L. Catalano; G. De Sabbata; R. Rizzi; C. Feo; R. Mazza; G. Farina; A. Spadano; F. Pisani; L. Podda; G. Aitoro; V. Magarotto; M. Astolfi; F. Di Raimondo; G. Gaidano; M. Boccadoro
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
2018-01-01 Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN MULTIPLE MYELOMA: THE GITMO EXPERIENCE | 2003 | Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavaro P; Rotta M; Aitoro G; Corradini P; Todisco E; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Messina M; Palumbo A; Sandmaier B; Storb R; Boccadoro M | |
| Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib | 2016 | Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.* | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS | 2015 | Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS | 2015 | Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Pasquale, R; Sica, S; Laurenti, L | |
| Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin. | 1988 | VISANI G ;RIZZOLI V ;DINOTA A ;AGLIETTA M ;BERNABEI PA ;GERACI L ;LEONI P ;MANGONI L ;MELONI G ;MOTTA MR | |
| Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis | 2002 | Fabris, Fabrizio; Fagioli, Franca; Basso, Giuseppe; Girolami, Antonio | |
| B lymphocytes receptors: a new biological approach for immunofluorescence studies. | 1977 | CONTE PF ;BOCCADORO M ;PILERI A | |
| A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines | 2019 | D'Agaro T.; Zucchetto A.; Vit F.; Bittolo T.; Tissino E.; Rossi F.M.; Degan M.; Zaja F.; Bulian P.; Bo M.D.; Ferrero S.; Ladetto M.; Zamo A.; Gattei V.; Bomben R. | |
| A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial | 2018 | Bomben, Riccardo; Ferrero, Simone; D'Agaro, Tiziana; Dal Bo, Michele; Re, Alessandro; Evangelista, Andrea; Carella, Angelo Michele; Zamò, Alberto; Vitolo, Umberto; Omedè, Paola; Rusconi, Chiara; Arcaini, Luca; Rigacci, Luigi; Luminari, Stefano; Piccin, Andrea; Liu, Delong; Wiestner, Adrien; Gaidano, Gianluca; Cortelazzo, Sergio; Ladetto, Marco; Gattei, Valter | |
| Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress | 2011 | L. Oliva; G. Palladini; F. Cerruti; N. Pengo; P. Cascio; R. Sitia; G. Merlini; S. Cenci | |
| BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. | 2014 | Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
| Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia | 2019 | Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide | |
| Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. | 2006 | Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A | |
| Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy. | 2014 | Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A | |
| Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse | 2005 | MATTEI D; MORDINI N; VIGNA TAGLIANTI R; BRUNO B; RAPEZZI D; GALLAMINI A | |
| Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation | 2006 | BRUNO B; PATRIARCA F; SORASIO R; MATTEI D; MONTEFUSCO V; PECCATORI J; BONIFAZI F; PETRUCCI MT; MILONE G; GUIDI S; GIACCONE L; ROTTA M; FANIN R; BOCCADORO M; CORRADINI P | |
| BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT)VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) INELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE,RANDOMIZED, PHASE III STUDY | 2009 | A. Palumbo; S. Bringhen; D. Rossi; R. Ria; S. Berretta; M. Offidani; F. Patriarca; C. Nozzoli; A. Levi; T. Guglielmelli; G. Benevolo; V. Callea; A.M. Liberati; C. Crippa; N. Di Renzo; L. Catalano; G. De Sabbata; R. Rizzi; C. Feo; R. Mazza; G. Farina; A. Spadano; F. Pisani; L. Podda; G. Aitoro; V. Magarotto; M. Astolfi; F. Di Raimondo; G. Gaidano; M. Boccadoro | |
| Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) | 2018 | Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile